$SURF Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Surface Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Surface Oncology, Inc.. Get notifications about new insider transactions in Surface Oncology, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Option Exercise | M | 4.14 | 10,273 | 42,530 | 93,831 | |
Jun 11 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Option Exercise | M | 4.14 | 34,727 | 143,770 | 10,325 | |
Jun 11 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Option Exercise | M | 4.14 | 200,000 | 828,000 | 104,104 | |
Jun 11 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Sell | S | 7.61 | 15,273 | 116,226 | 257,000 | 272.3 K to 257 K (-5.61 %) |
Jun 11 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Buy | M | 4.14 | 10,273 | 42,530 | 272,273 | 262 K to 272.3 K (+3.92 %) |
Jun 11 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Sell | S | 7.66 | 234,727 | 1,798,619 | 262,000 | 496.7 K to 262 K (-47.25 %) |
Jun 11 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Buy | M | 4.14 | 34,727 | 143,770 | 496,727 | 462 K to 496.7 K (+7.52 %) |
Jun 11 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Buy | M | 4.14 | 200,000 | 828,000 | 462,000 | 262 K to 462 K (+76.34 %) |
May 05 2021 | SURF | Surface Oncology, ... | ONEILL ALISON | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 7.33 | 30,000 | 219,900 | 30,000 | |
May 05 2021 | SURF | Surface Oncology, ... | RATH HENRY C. | Chief Business Offi ... | Option Exercise | A | 7.33 | 140,000 | 1,026,200 | 140,000 | |
May 05 2021 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | A | 7.33 | 30,000 | 219,900 | 30,000 | |
Apr 02 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Option Exercise | A | 8.09 | 4,425 | 35,798 | 4,425 | |
Apr 02 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Option Exercise | A | 8.09 | 35,400 | 286,386 | 35,400 | |
Apr 02 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Option Exercise | A | 8.09 | 15,000 | 121,350 | 15,000 | |
Apr 02 2021 | SURF | Surface Oncology, ... | Goater Jeff | Director | Option Exercise | A | 8.09 | 15,000 | 121,350 | 15,000 | |
Mar 03 2021 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Option Exercise | A | 11.24 | 484,280 | 5,443,307 | 484,280 | |
Mar 03 2021 | SURF | Surface Oncology, ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | A | 9.02 | 82,000 | 739,640 | 82,000 | |
Mar 03 2021 | SURF | Surface Oncology, ... | Nogelo Liisa I | Chief Legal Officer | Option Exercise | A | 9.02 | 82,000 | 739,640 | 82,000 | |
Mar 03 2021 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | A | 9.02 | 68,000 | 613,360 | 68,000 | |
Feb 18 2021 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Sell | S | 11.35 | 1,000 | 11,350 | 88,000 | 89 K to 88 K (-1.12 %) |
Feb 09 2021 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Sell | S | 12.45 | 1,500 | 18,675 | 99,183 | 100.7 K to 99.2 K (-1.49 %) |
Feb 09 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Option Exercise | M | 3.18 | 2,500 | 7,950 | 247,000 | |
Feb 09 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Sell | S | 12.50 | 2,500 | 31,250 | 262,000 | 264.5 K to 262 K (-0.95 %) |
Feb 09 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Buy | M | 3.18 | 2,500 | 7,950 | 264,500 | 262 K to 264.5 K (+0.95 %) |
Feb 03 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Option Exercise | M | 3.18 | 2,500 | 7,950 | 249,500 | |
Feb 03 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Sell | S | 10.69 | 2,500 | 26,718 | 262,000 | 264.5 K to 262 K (-0.95 %) |
Feb 03 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Buy | M | 3.18 | 2,500 | 7,950 | 264,500 | 262 K to 264.5 K (+0.95 %) |
Feb 03 2021 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Sell | S | 11.19 | 1,500 | 16,785 | 100,683 | 102.2 K to 100.7 K (-1.47 %) |
Jan 21 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Option Exercise | M | 3.18 | 5,000 | 15,900 | 252,000 | |
Jan 21 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Sell | S | 13.00 | 5,000 | 65,000 | 262,000 | 267 K to 262 K (-1.87 %) |
Jan 21 2021 | SURF | Surface Oncology, ... | Goater Jeff | Chief Executive Off ... | Buy | M | 3.18 | 5,000 | 15,900 | 267,000 | 262 K to 267 K (+1.91 %) |
Jan 15 2021 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Sell | S | 12.25 | 2,000 | 24,500 | 89,000 | 91 K to 89 K (-2.20 %) |
Jan 15 2021 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Sell | S | 11.95 | 7,000 | 83,650 | 91,000 | 98 K to 91 K (-7.14 %) |
Dec 21 2020 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Sell | S | 18.10 | 1,700,000 | 30,770,000 | 2,945,453 | 4.6 M to 2.9 M (-36.59 %) |
Dec 21 2020 | SURF | Surface Oncology, ... | Atlas Venture Fund IX, L.P. | 10% Owner | Sell | S | 18.10 | 1,700,000 | 30,770,000 | 2,945,453 | 4.6 M to 2.9 M (-36.59 %) |
Dec 17 2020 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Sell | S | 10.48 | 1,000 | 10,480 | 98,000 | 99 K to 98 K (-1.01 %) |
Dec 15 2020 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Sell | S | 10.05 | 1,405 | 14,120 | 99,000 | 100.4 K to 99 K (-1.40 %) |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.27 | 1 | 4 | 25,999 | |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 5.41 | 982 | 5,315 | 2,654 | |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.27 | 173 | 739 | 13,905 | |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.14 | 227 | 939 | 455 | |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.27 | 1 | 4 | 102,183 | 102.2 K to 102.2 K (0.00 %) |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.27 | 1 | 4 | 25,999 | |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 5.41 | 982 | 5,315 | 102,182 | 101.2 K to 102.2 K (+0.97 %) |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 5.41 | 982 | 5,315 | 2,654 | |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.27 | 173 | 739 | 101,200 | 101 K to 101.2 K (+0.17 %) |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.27 | 173 | 739 | 13,905 | |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.14 | 227 | 939 | 101,027 | 100.8 K to 101 K (+0.23 %) |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.14 | 227 | 939 | 455 | |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.27 | 1 | 4 | 102,183 | 102.2 K to 102.2 K (0.00 %) |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 5.41 | 982 | 5,315 | 102,182 | 101.2 K to 102.2 K (+0.97 %) |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.27 | 173 | 739 | 101,200 | 101 K to 101.2 K (+0.17 %) |
Nov 27 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.14 | 227 | 939 | 101,027 | 100.8 K to 101 K (+0.23 %) |
Nov 13 2020 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Sell | S | 10.05 | 595 | 5,980 | 100,405 | 101 K to 100.4 K (-0.59 %) |
Oct 30 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.27 | 122 | 521 | 14,078 | |
Oct 30 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.14 | 4,773 | 19,741 | 682 | |
Oct 30 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.27 | 122 | 521 | 14,078 | |
Oct 30 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.27 | 122 | 521 | 100,800 | 100.7 K to 100.8 K (+0.12 %) |
Oct 30 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.14 | 4,773 | 19,741 | 682 | |
Oct 30 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.14 | 4,773 | 19,741 | 100,678 | 95.9 K to 100.7 K (+4.98 %) |
Oct 30 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.27 | 122 | 521 | 100,800 | 100.7 K to 100.8 K (+0.12 %) |
Oct 30 2020 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.14 | 4,773 | 19,741 | 100,678 | 95.9 K to 100.7 K (+4.98 %) |
Sep 03 2020 | SURF | Surface Oncology, ... | EcoR1 Capital, LLC | 10% Owner | Sell | S | 7.14 | 332,780 | 2,376,681 | 4,701,081 | 5 M to 4.7 M (-6.61 %) |
Jun 12 2020 | SURF | Surface Oncology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
Jun 12 2020 | SURF | Surface Oncology, ... | Ibrahim Ramy | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
Jun 12 2020 | SURF | Surface Oncology, ... | Stelzer Laurie | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
Jun 12 2020 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
Jun 12 2020 | SURF | Surface Oncology, ... | MCDONOUGH GEOFF | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
Jun 12 2020 | SURF | Surface Oncology, ... | LYNCH DANIEL | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
Jun 12 2020 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
May 22 2020 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Sell | S | 3.66 | 420,000 | 1,535,562 | 2,892,877 | 3.3 M to 2.9 M (-12.68 %) |
Oct 03 2019 | SURF | Surface Oncology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 1.17 | 13,572 | 15,879 | 13,572 | |
Oct 03 2019 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 1.17 | 16,531 | 19,341 | 16,531 | |
Oct 03 2019 | SURF | Surface Oncology, ... | Ibrahim Ramy | Director | Option Exercise | A | 1.17 | 24,200 | 28,314 | 24,200 | |
Oct 03 2019 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Option Exercise | A | 1.17 | 14,965 | 17,509 | 14,965 | |
Jul 02 2019 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Option Exercise | A | 2.79 | 6,280 | 17,521 | 6,280 | |
Jul 02 2019 | SURF | Surface Oncology, ... | MCDONOUGH GEOFF | Director | Option Exercise | A | 2.79 | 3,834 | 10,697 | 3,834 | |
Jun 06 2019 | SURF | Surface Oncology, ... | Stelzer Laurie | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | MCDONOUGH GEOFF | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | LYNCH DANIEL | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | Stelzer Laurie | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | MCDONOUGH GEOFF | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | LYNCH DANIEL | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
Jun 06 2019 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
May 02 2019 | SURF | Surface Oncology, ... | Dwyer Wendy | Chief Business Offi ... | Option Exercise | A | 4.77 | 125,000 | 596,250 | 125,000 | |
Apr 02 2019 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 0.35 | 2,728 | 960 | 0 | |
Apr 02 2019 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 0.35 | 2,728 | 960 | 50,905 | 48.2 K to 50.9 K (+5.66 %) |
Jan 08 2019 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Option Exercise | M | 4.14 | 25,000 | 103,400 | 256,578 | |
Jan 08 2019 | SURF | Surface Oncology, ... | ROSS ROBERT W. | Chief Medical Offic ... | Buy | M | 4.14 | 25,000 | 103,400 | 25,000 | 0 to 25 K |
Jan 08 2019 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 4.14 | 455 | 1,882 | 5,455 | |
Jan 08 2019 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Option Exercise | M | 0.35 | 1,818 | 640 | 2,728 | |
Jan 08 2019 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 4.14 | 455 | 1,882 | 48,177 | 47.7 K to 48.2 K (+0.95 %) |
Jan 08 2019 | SURF | Surface Oncology, ... | FEES JESSICA | See Remarks | Buy | M | 0.35 | 1,818 | 640 | 47,722 | 45.9 K to 47.7 K (+3.96 %) |
Aug 01 2018 | SURF | Surface Oncology, ... | Nogelo Liisa I | General Counsel | Option Exercise | A | 11.54 | 115,000 | 1,327,100 | 115,000 | |
Jul 05 2018 | SURF | Surface Oncology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 16.83 | 8,882 | 149,484 | 8,882 | |
Apr 25 2018 | SURF | Surface Oncology, ... | FIL Ltd | Option Exercise | C | 0.00 | 1,950,777 | 0 | 0 | ||
Apr 25 2018 | SURF | Surface Oncology, ... | FIL Ltd | Buy | C | 0.00 | 886,716 | 0 | 886,716 | 0 to 886.7 K | |
Apr 25 2018 | SURF | Surface Oncology, ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 4,155,773 | 0 | 0 | |
Apr 25 2018 | SURF | Surface Oncology, ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 4,155,773 | 0 | 0 | |
Apr 25 2018 | SURF | Surface Oncology, ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 1,888,986 | 0 | 1,888,986 | 0 to 1.9 M |
Apr 25 2018 | SURF | Surface Oncology, ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 1,888,986 | 0 | 1,888,986 | 0 to 1.9 M |
Apr 25 2018 | SURF | Surface Oncology, ... | October 2017 Liquidating Trust | Option Exercise | C | 0.00 | 893,450 | 0 | 0 | ||
Apr 25 2018 | SURF | Surface Oncology, ... | October 2017 Liquidating Trust | Buy | C | 0.00 | 406,113 | 0 | 406,113 | 0 to 406.1 K | |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Sonsini Peter W. | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Sonsini Peter W. | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Sonsini Peter W. | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Sonsini Peter W. | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Sonsini Peter W. | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Sonsini Peter W. | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | MOTT DAVID M | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | KERINS PATRICK J | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | KERINS PATRICK J | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | KERINS PATRICK J | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | MOTT DAVID M | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | KERINS PATRICK J | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | KERINS PATRICK J | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BASKETT FOREST | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | KERINS PATRICK J | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRIS PETER J | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 |